Gutierrez Jose, Marshall Randolph S, Lazar Ronald M
Department of Neurology, Columbia University Medical Center, New York, New York.
JAMA Neurol. 2015 Mar;72(3):309-15. doi: 10.1001/jamaneurol.2014.3873.
Whether cognition is influenced by arterial stiffness in the absence of vascular disease remains uncertain.
To test the hypotheses that indirect measures of arterial stiffness are important predictors of cognitive performance and that this relationship varies depending on the presence of vascular disease.
DESIGN, SETTING, AND PARTICIPANTS: Participants included 2573 noninstitutionalized US adults randomly selected from 2 cycles of the National Health and Nutrition Examination Survey (1999-2002). The sample was stratified by groups based on the presence (VASC+) vs the absence (VASC-) of vascular variables negatively associated with cognition to assess the effects of indirect measures of arterial stiffness on cognitive performance. We used logistic regression to obtain odds ratios (ORs) and their 95% CIs. P < .05 was considered statistically significant.
The Digit Symbol Substitution Test score was used as a continuous variable, and the lowest quintile was designated as an indicator of poorer cognitive performance.
In the VASC+ group, poorer cognitive performance was more likely with increasing age (OR, 1.12 [95% CI, 1.08-1.17]; P < .001), a sedentary lifestyle (OR, 2.99 [95% CI, 1.62-5.55]; P = .002), and the use of dihydropyridine calcium channel blockers (OR, 9.24 [95% CI, 1.35-63.23]; P = .02). Poorer cognitive performance in the VASC+ group was less likely in women (OR, 0.37 [95% CI, 0.18-0.72]; P = .02), non-Hispanic white individuals (OR, 0.16 [95% CI, 0.09-0.26]; P < .001), those with higher educational attainment (OR, 0.23 [95% CI, 0.14-0.38]; P < .001), those with higher income levels (OR, 0.56 [95% CI, 0.72-0.76]; P < .001), and those who used renin-angiotensin system blockers (OR, 0.24 [95% CI, 0.07-0.79]; P = .02). In the VASC- group, the most important significant predictors of poorer cognitive performance were an ankle brachial index greater than 1.30 (OR, 18.56 [95% CI, 2.94-117.05]; P = .002) and increased blood pressure variability (OR, 3.49 [95% CI, 1.07-11.35]; P = .04). Among participants in the VASC- group who had both of these variables, the prevalence of poorer cognitive performance was greater (β = 16.65; P < .001).
Two indirect measures of arterial stiffness, an ankle brachial index greater than 1.30 and increased blood pressure variability, are associated with poorer cognitive performance among adults 60 years or older without clinical atherosclerotic disease. Among those with vascular disease, factors capable of influencing arterial stiffness, such as exercise and the use of renin-angiotensin system blockers, may be protective against poorer cognitive performance.
在没有血管疾病的情况下,认知是否受动脉僵硬度影响仍不确定。
检验以下假设,即动脉僵硬度的间接测量指标是认知表现的重要预测因素,且这种关系因血管疾病的存在与否而不同。
设计、设置和参与者:参与者包括从国家健康与营养检查调查的2个周期(1999 - 2002年)中随机选取的2573名非机构化美国成年人。根据与认知呈负相关的血管变量的存在(VASC +)与不存在(VASC -)情况将样本分层,以评估动脉僵硬度间接测量指标对认知表现的影响。我们使用逻辑回归来获得比值比(OR)及其95%置信区间(CI)。P < 0.05被认为具有统计学意义。
数字符号替换测验得分用作连续变量,最低五分位数被指定为认知表现较差的指标。
在VASC +组中,随着年龄增长(OR,1.12 [95% CI,1.08 - 1.17];P < 0.001)、久坐不动的生活方式(OR,2.99 [95% CI,1.62 - 5.55];P = 0.002)以及使用二氢吡啶类钙通道阻滞剂(OR,9.24 [95% CI,1.35 - 63.23];P = 0.02),认知表现较差的可能性增加。VASC +组中,女性(OR,0.37 [95% CI,0.18 - 0.72];P = 0.02)、非西班牙裔白人个体(OR,0.16 [95% CI,0.09 - 0.26];P < 0.001)、受教育程度较高者(OR,0.23 [95% CI,0.14 - 0.38];P < 0.001)、收入水平较高者(OR,0.56 [95% CI,0.72 - 0.76];P < 0.001)以及使用肾素 - 血管紧张素系统阻滞剂者(OR,0.24 [95% CI,0.07 - 0.79];P = 0.02)认知表现较差的可能性较小。在VASC -组中,认知表现较差最重要的显著预测因素是踝臂指数大于1.30(OR,18.56 [95% CI,2.94 - 117.05];P = 0.002)和血压变异性增加(OR,3.49 [95% CI,1.07 - 11.35];P = 0.04)。在VASC -组中同时具有这两个变量的参与者中,认知表现较差的患病率更高(β = 16.65;P < 0.001)。
两个动脉僵硬度间接测量指标,即踝臂指数大于1.30和血压变异性增加,与60岁及以上无临床动脉粥样硬化疾病成年人的认知表现较差相关。在患有血管疾病的人群中,能够影响动脉僵硬度的因素,如运动和使用肾素 - 血管紧张素系统阻滞剂,可能对预防认知表现较差具有保护作用。